Physician profile
Ali Mahmood
NPI 1548439888
$7,172.15
in general payments reported to CMS, 2019-2025
12 companies · $3,983 in 2025
The $3,983 reported for 2025 was more than what 86% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,490 · 2020: $191 · 2021: $674 · 2022: $705 · 2023: $115 · 2024: $14.58 · 2025: $3,983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Consulting Fee: $880 · Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Consulting Fee | $880.00 |
| Food and Beverage | $232.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $3,035.99 | 2025 | Gelport Laparoscopic System |
| Covidien LP | $1,200.00 | 2019 | |
| Medtronic, INC. | $1,058.71 | 2021-2025 | Signia |
| Ethicon US, LLC | $934.35 | 2022-2025 | Harmonic, Echelon; Endopath |
| Smith+Nephew, INC. | $449.01 | 2019-2021 | |
| Boston Scientific Corporation | $190.09 | 2022 | |
| Abbott Laboratories | $115.42 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $99.98 | 2023 | |
| Solventum Corporation | $33.23 | 2024-2025 | Activ.A.C. |
| Ferring Pharmaceuticals INC. | $20.20 | 2020 | |
| Intuitive Surgical, INC. | $20.13 | 2019 | |
| Kerecis Limited | $15.04 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Mahmood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.